HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Mar 31, 2023
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Sale
Common Stock
2023-03-30$22.77/sh−2,627$59,817→ 114,576 total
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.